Close Menu

Biocept

NEW YORK (GenomeWeb) – Biocept reported today that its third quarter net loss increased 34 percent year over year, as the firm expanded initiatives in its fledgling oncology diagnostics business.

NEW YORK (GenomeWeb) — Biocept and Rosetta Genomics said this week that they will pair Biocept's circulating tumor cell isolation technology with Rosetta's microRNA analysis platforms to investigate the possibility of developing blood-based cancer diagnostics and therapeutic response assays.

NEW YORK (GenomeWeb) — Biocept and Rosetta Genomics said today that they will collaborate in the area of cancer diagnostics.

NEW YORK (GenomeWeb) — Biocept said today that it has expanded its collaboration with the University of Texas MD Anderson Cancer Center in the area of ovarian cancer.

NEW YORK (GenomeWeb) — Diagnologix, a year-old startup developing microbubble-based sample prep technology, has been awarded a $25,000 grant as part of the company's acceptance into I-Corps, a recently established business-development program from the National Institutes of Health and National Sc

This article has been updated from a previous version to more accurately characterize cell-free DNA (cfDNA) as circulating tumor DNA (ctDNA).

NEW YORK (GenomeWeb) – Biocept today reported a 60 percent drop in its second quarter revenues.

Asuragen said this week that it has appointed Matthew McManus as CEO and president.

Biocept announced the hiring of Amy McNeal as its new senior director of managed care and reimbursement strategies. Biocept is a molecular diagnostics firm specializing in analysis of biomarkers from circulating tumor cells and DNA.

The headline has been corrected to state that Biocept's first quarter revenues decreased, not increased, 20 percent.
NEW YORK (GenomeWeb) – Newly publicly traded firm Biocept yesterday reported a 20 percent drop year over year in its first quarter revenues.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.